Sun Pharmaceutical Industries Ltd.

The sales surged to Rs. 59482.20 millions, up 48.45% for the March 2023 quarter as against Rs. 40068.80 millions during the corresponding quarter previous year.The Net Loss for the quarter ended March 2023 is Rs. -10208.20 millions as compared to Net Loss of Rs. -12862.10 millions of corresponding quarter ended March 2022OP of the company witnessed a marginal growth to 24809.50 millions from 13002.50 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202303	202203	% Var	202303	202203	% Var	202303	202203	% Var
Sales	59482.20	40068.80	48.45	208121.40	155859.80	33.53	208121.40	155859.80	33.53
Other Income	1203.00	4404.90	-72.69	3292.90	11968.80	-72.49	3292.90	11968.80	-72.49
PBIDT	24809.50	13002.50	90.81	67518.90	38654.40	74.67	67518.90	38654.40	74.67
Interest	1614.50	911.90	77.05	4721.80	3881.00	21.66	4721.80	3881.00	21.66
PBDT	-6182.90	-4459.00	38.66	33419.20	16568.10	101.71	33419.20	16568.10	101.71
Depreciation	4119.80	3541.40	16.33	16008.70	13499.50	18.59	16008.70	13499.50	18.59
PBT	-10302.70	-8000.40	28.78	17410.50	3068.60	467.38	17410.50	3068.60	467.38
TAX	-94.50	4861.70	-101.94	503.30	4068.50	-87.63	503.30	4068.50	-87.63
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	-10208.20	-12862.10	-20.63	16907.20	-999.90	-1790.89	16907.20	-999.90	-1790.89
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	41.71	32.45	28.53	32.44	24.80	30.81	32.44	24.80	30.81